Role of non-coding RNA in lineage plasticity of prostate cancer
The treatment of prostate cancer (PCa) has made great progress in recent years, but treatment resistance always develops and can even lead to fatal…
Category: Prostate cancer
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study
Alkaline phosphatase (ALP) declines and pain responses can occur during radium-223 (223Ra) treatment, but their association with treatme…
Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study
Prostate cancer (PCa) is a heterogeneous disease affecting over 14% of the male population worldwide. Although patients often respond positively to…
EphB4-ephrin-B2 are targets in castration resistant prostate cancer
PI3K pathway activation is a common and early event in prostate cancer, from loss of function mutations in PTEN, or activating mutations in …